Study to Assess Efficacy and Safety of Baloxavir Marboxil In Combination With Standard-of-Care Neuraminidase Inhibitor In Hospitalized Participants With Severe Influenza
Clinical trial NCT03684044 · COMPLETED
Trial details
- NCT number
- NCT03684044
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-08
- Primary completion
- 2020-03-16
- Enrollment
- 363
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.